139 related articles for article (PubMed ID: 7865883)
1. Separation of v-Src-induced mitogenesis and morphological transformation by inhibition of AP-1.
Frame MC; Simpson K; Fincham VJ; Crouch DH
Mol Biol Cell; 1994 Nov; 5(11):1177-84. PubMed ID: 7865883
[TBL] [Abstract][Full Text] [Related]
2. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
Catling AD; Wyke JA; Frame MC
Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
[TBL] [Abstract][Full Text] [Related]
3. Uncoupling of the pathways which link MAP kinase to c-fos transcription and AP-1 in response to growth stimuli.
Wyke AW; Lang A; Frame MC
Cell Signal; 1996 Feb; 8(2):131-9. PubMed ID: 8730515
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic action of AP-1 in v-Src-transformed cells.
Wang L; Rodrigues NA; Wu Y; Maslikowski BM; Singh N; Lacroix S; Bédard PA
J Virol; 2011 Jul; 85(13):6725-35. PubMed ID: 21507983
[TBL] [Abstract][Full Text] [Related]
5. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
Murakami M; Sonobe MH; Ui M; Kabuyama Y; Watanabe H; Wada T; Handa H; Iba H
Oncogene; 1997 May; 14(20):2435-44. PubMed ID: 9188858
[TBL] [Abstract][Full Text] [Related]
7. JunD/AP-1 Antagonizes the Induction of DAPK1 To Promote the Survival of v-Src-Transformed Cells.
Maślikowski BM; Wang L; Wu Y; Fielding B; Bédard PA
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795443
[TBL] [Abstract][Full Text] [Related]
8. Multiple signaling pathways control the activation of the CEF-4/9E3 cytokine gene by pp60v-src.
Bojović B; Rodrigues N; Dehbi M; Bédard PA
J Biol Chem; 1996 Sep; 271(37):22528-37. PubMed ID: 8798420
[TBL] [Abstract][Full Text] [Related]
9. Analysis of AP-1 function in cellular transformation pathways.
Suzuki T; Murakami M; Onai N; Fukuda E; Hashimoto Y; Sonobe MH; Kameda T; Ichinose M; Miki K; Iba H
J Virol; 1994 Jun; 68(6):3527-35. PubMed ID: 8189491
[TBL] [Abstract][Full Text] [Related]
10. The constitutive activation of the CEF-4/9E3 chemokine gene depends on C/EBPbeta in v-src transformed chicken embryo fibroblasts.
Gagliardi M; Maynard S; Bojovic B; Bédard PA
Oncogene; 2001 Apr; 20(18):2301-13. PubMed ID: 11402325
[TBL] [Abstract][Full Text] [Related]
11. AP-1 factors play an important role in transformation induced by the v-rel oncogene.
Kralova J; Liss AS; Bargmann W; Bose HR
Mol Cell Biol; 1998 May; 18(5):2997-3009. PubMed ID: 9566919
[TBL] [Abstract][Full Text] [Related]
12. Suppression of cellular transformation by glucocorticoid receptor mutants.
Kameda T; Iba H
Cancer Res; 1998 Mar; 58(5):867-70. PubMed ID: 9500440
[TBL] [Abstract][Full Text] [Related]
13. Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.
Hawker KL; Pintzas A; Hennigan RF; Gillespie DA; Ozanne BW
J Virol; 1993 Sep; 67(9):5487-95. PubMed ID: 8350408
[TBL] [Abstract][Full Text] [Related]
14. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
15. Intracellular targeting of pp60src expression: localization of v-src to adhesion plaques is sufficient to transform chicken embryo fibroblasts.
Liebl EC; Martin GS
Oncogene; 1992 Dec; 7(12):2417-28. PubMed ID: 1334249
[TBL] [Abstract][Full Text] [Related]
16. Mitogenesis induced by pp60v-src is not accompanied by increased expression of immediate early response genes.
Welham MJ; Wyke JA; Lang A; Wyke AW
Oncogene; 1990 Feb; 5(2):161-9. PubMed ID: 2108404
[TBL] [Abstract][Full Text] [Related]
17. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
19. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
20. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
